Academic Staff

Home > People > Academic Staff

Professor David Shu-cheong HUI (許樹昌教授)

MBBS (UNSW), MD(UNSW), FRACP, FRCP (Lond, Glasg, Edin), FHKCP, FHKAM 

Associate Director (Clinical Liaison)

JC School of Public Health and Primary Care

 

Director, Stanley Ho Centre for Emerging Infections Diseases

Email: dschui@cuhk.edu.hk

 

Personal Website: http://www.cuhk.edu.hk/med/ceid/people__davidhui.htm

Division

Division of Infectious Diseases

Biography

Dr Hui graduated from the University of New South Wales in 1985. He then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia.

Dr Hui was heavily involved in the clinical management of patients with SARS during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He has contributed to the WHO treatment guidelines (including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome) and the WHO training workshop in the clinical management of influenza A(H7N9) and other severe acute respiratory infections in May 2014.

Dr Hui has published over 220 peer-reviewed journal articles and 23 book chapters since joining the CUHK in 1998. His research interests include clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the infection control in the medical ward environment in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.

Research Interest

Clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the efficacy of the medical ward airflow in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.

 

Selected Publications 

  1. Lee N, Hui DS. Potential and challenges of serotherapy for severe influenza. Lancet Respir Med. 2017;5(8):e27.

  2. Lee N, Wong CK, Chan MCW, Yeung ES, Tam WW, Tsang OT, Choi KW, Chan, PK., Kwok A, Lui GCY, Leung WS, Yung IMH, Wong RYK, Cheung CSK, Hui DSC. Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial. ANTIVIRAL RESEARCH. 2017;144 :48-56.

  3. Lee N, Chan PK, Tam WW, Chan MC, Lui GC, Kwok AK, Ko FW, Ng SS, Yung IMH, Wong RYK, Hui DSC. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2016 ;48 : 215-219.

  4. Hui DS. Super-spreading events of MERS-CoV infection. LANCET. 2016 ;388: 942-943.

  5. Lee N, Leo YS, Cao B, Chan PKS, Kyaw WM, Uyeki TM, Tam WW, Cheung CSK, Yung IMH, Li H, Gu L, Liu Y, Liu Z, Qu J, Hui DSC. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. EUROPEAN RESPIRATORY JOURNAL. 2015 ;45 : 1642-1652.

  6. Lee N, Chan MCW, Lui GCY, Li R, Wong RYK, Yung IMH, Cheung CSK, Chan ECY, Hui DSC., Chan, P.K.S. High viral load and respiratory failure in adults hospitalized for respiratory syncytial virus infections. JOURNAL OF INFECTIOUS DISEASES. 2015; 212: 1237-1240

  7. Hui DS, Lee N, Chan PKS. Update in viral infections 2014. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2015; 192: 676-681.

  8. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. LANCET 2015;386: 995-1007.

  9. Hui DS, Perlman S, Zumla A. Spread of MERS to South Korea and China. LANCET RESPIRATORY MEDICINE. 2015; 3: 509-510.

  10. Zumla A, Memish ZA, Maeurer M, Bates M, Mwaba P, Al-Tawfiq JA, Denning DW, Hayden FG, Hui DS. Emerging novel and antimicrobial-resistant respiratory tract infections: New drug development and therapeutic options. LANCET INFECTIOUS DISEASES. 2014 ;14: 1136-1149.

Please reload